| 1 |
34783281 |
10.1080/10428194.2021.1999444 |
2022 |
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. |
BCL10 |
| 2 |
34906687 |
10.1016/j.fsi.2021.12.009 |
2022 |
BCL10 regulates the production of proinflammatory cytokines by activating MAPK-NF-κB/Rel signaling pathway in oysters. |
BCL10 |
| 3 |
35192832 |
10.1016/j.scitotenv.2022.153990 |
2022 |
Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. |
BCL10 |
| 4 |
35218741 |
10.1016/j.bcp.2022.114977 |
2022 |
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases. |
BCL10 |
| 5 |
35230873 |
10.1126/scisignal.abk3083 |
2022 |
Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells. |
BCL10 |
| 6 |
35406516 |
10.3390/cancers14071742 |
2022 |
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. |
BCL10 |
| 7 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
BCL10 |
| 8 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
BCL10 |
| 9 |
35658124 |
10.1158/2159-8290.CD-21-1566 |
2022 |
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. |
BCL10 |
| 10 |
35750252 |
10.1016/j.clim.2022.109067 |
2022 |
BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency. |
BCL10 |
| 11 |
35929131 |
10.1158/2159-8290.CD-22-0614 |
2022 |
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine. |
BCL10 |
| 12 |
35981904 |
10.1016/j.jaci.2022.06.023 |
2022 |
The role of the CBM complex in allergic inflammation and disease. |
BCL10 |
| 13 |
36094731 |
10.1007/s12104-022-10105-3 |
2022 |
Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL<sub>3</sub> domain in solution. |
BCL10 |
| 14 |
32855441 |
10.1038/s41379-020-00660-2 |
2021 |
Deciphering the genetic landscape of pulmonary lymphomas. |
BCL10 |
| 15 |
33640899 |
10.1038/s41392-021-00477-8 |
2021 |
TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. |
BCL10 |
| 16 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
BCL10 |
| 17 |
33872653 |
10.1016/j.jaci.2021.04.006 |
2021 |
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency. |
BCL10 |
| 18 |
33941870 |
10.1038/s41418-021-00787-y |
2021 |
USP12 promotes CD4<sup>+</sup> T cell responses through deubiquitinating and stabilizing BCL10. |
BCL10 |
| 19 |
34412631 |
10.1186/s12935-021-02143-z |
2021 |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling. |
BCL10 |
| 20 |
34826258 |
10.1126/sciimmunol.abi4425 |
2021 |
Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation. |
BCL10 |
| 21 |
34928543 |
10.1002/iub.2581 |
2021 |
BCL10 correlates with bad prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. |
BCL10 |
| 22 |
31241148 |
10.1093/cvr/cvz169 |
2020 |
B-cell lymphoma/leukaemia 10 and angiotensin II-induced kidney injury. |
BCL10 |
| 23 |
31757436 |
10.1016/j.pathol.2019.08.012 |
2020 |
Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches. |
BCL10 |
| 24 |
31774199 |
10.15252/embj.2019102030 |
2020 |
Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis. |
BCL10 |
| 25 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
BCL10 |
| 26 |
31961340 |
10.1172/JCI97040 |
2020 |
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. |
BCL10 |
| 27 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
BCL10 |
| 28 |
32164050 |
10.4143/crt.2019.606 |
2020 |
Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway. |
BCL10 |
| 29 |
32179489 |
10.1016/j.cancergen.2020.02.005 |
2020 |
Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma. |
BCL10 |
| 30 |
32683230 |
10.1016/j.jtemb.2020.126615 |
2020 |
Zinc homeostasis plays an important role in the prevention of obesity-induced cardiac inflammation, remodeling and dysfunction. |
BCL10 |
| 31 |
32721634 |
10.1016/j.cellimm.2020.104158 |
2020 |
Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist. |
BCL10 |
| 32 |
33052237 |
10.7150/thno.47533 |
2020 |
Targeting BCL10 by small peptides for the treatment of B cell lymphoma. |
BCL10 |
| 33 |
33297339 |
10.3390/nu12123755 |
2020 |
Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells. |
BCL10 |
| 34 |
30773504 |
10.5582/bst.2018.01291 |
2019 |
By regulating miR-182-5p/BCL10/CYCS, sufentanil reduces the apoptosis of umbilical cord mesenchymal stem cells caused by ropivacaine. |
BCL10 |
| 35 |
31047877 |
10.1016/j.cca.2019.04.077 |
2019 |
BCL10 in cell survival after DNA damage. |
BCL10 |
| 36 |
31060714 |
10.1016/j.jaci.2019.03.009 |
2019 |
Germline CBM-opathies: From immunodeficiency to atopy. |
BCL10 |
| 37 |
31391255 |
10.1074/jbc.RA119.009551 |
2019 |
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling. |
BCL10 |
| 38 |
31427546 |
NA |
2019 |
Characterisation of immunogenotypes of diffuse large B-cell lymphoma. |
BCL10 |
| 39 |
31554683 |
10.1128/JVI.01499-19 |
2019 |
Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons. |
BCL10 |
| 40 |
31644910 |
10.1016/j.celrep.2019.09.040 |
2019 |
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. |
BCL10 |
| 41 |
31658764 |
10.3390/ijms20205022 |
2019 |
B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration. |
BCL10 |
| 42 |
29289361 |
10.1016/j.blre.2017.12.001 |
2018 |
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. |
BCL10 |
| 43 |
29382759 |
10.1073/pnas.1721967115 |
2018 |
Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. |
BCL10 |
| 44 |
29765142 |
10.1038/s41379-018-0064-0 |
2018 |
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. |
BCL10 |
| 45 |
29925955 |
10.1038/s41586-018-0290-0 |
2018 |
A multiprotein supercomplex controlling oncogenic signalling in lymphoma. |
BCL10 |
| 46 |
29953499 |
10.1371/journal.pone.0199779 |
2018 |
Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells. |
BCL10 |
| 47 |
30022982 |
10.3389/fimmu.2018.01539 |
2018 |
BCL10 - Bridging CARDs to Immune Activation. |
BCL10 |
| 48 |
30206119 |
10.1074/jbc.RA118.004821 |
2018 |
Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9. |
BCL10 |
| 49 |
30279415 |
10.1038/s41467-018-06573-8 |
2018 |
Molecular architecture and regulation of BCL10-MALT1 filaments. |
BCL10 |
| 50 |
30283440 |
10.3389/fimmu.2018.02078 |
2018 |
The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex. |
BCL10 |
| 51 |
30283447 |
10.3389/fimmu.2018.02105 |
2018 |
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease. |
BCL10 |
| 52 |
30336982 |
10.1016/j.bbrc.2018.10.029 |
2018 |
MALT1 activation by TRAF6 needs neither BCL10 nor CARD11. |
BCL10 |
| 53 |
30386326 |
10.3389/fimmu.2018.02239 |
2018 |
Clinical and Genetic Heterogeneity of <i>CARD14</i> Mutations in Psoriatic Skin Disease. |
BCL10 |
| 54 |
30401751 |
10.1182/bloodadvances.2018022962 |
2018 |
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. |
BCL10 |
| 55 |
30474008 |
10.3389/fonc.2018.00498 |
2018 |
Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma. |
BCL10 |
| 56 |
30553470 |
10.1016/j.cancergen.2018.08.001 |
2018 |
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases. |
BCL10 |
| 57 |
26354285 |
10.1002/hon.2251 |
2017 |
Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma. |
BCL10 |
| 58 |
27864294 |
10.1182/blood-2016-05-718775 |
2017 |
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. |
BCL10 |
| 59 |
27873317 |
10.1002/path.4852 |
2017 |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21). |
BCL10 |
| 60 |
28158919 |
10.1111/jcmm.13050 |
2017 |
Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway. |
BCL10 |
| 61 |
28288707 |
10.1016/j.beha.2016.09.002 |
2017 |
MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism. |
BCL10 |
| 62 |
28672935 |
10.3892/etm.2017.4464 |
2017 |
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer. |
BCL10 |
| 63 |
28765954 |
10.3892/mmr.2017.7116 |
2017 |
In vitro reconstitution of interactions in the CARD9 signalosome. |
BCL10 |
| 64 |
29084984 |
10.1038/s41598-017-14102-8 |
2017 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma. |
BCL10 |
| 65 |
29225710 |
10.1007/s12308-017-0302-2 |
2017 |
Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. |
BCL10 |
| 66 |
29340061 |
10.18632/oncotarget.22799 |
2017 |
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. |
BCL10 |
| 67 |
26521038 |
10.1016/j.jaci.2015.09.016 |
2016 |
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. |
BCL10 |
| 68 |
26767426 |
10.1016/j.jid.2015.12.027 |
2016 |
MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. |
BCL10 |
| 69 |
26774590 |
10.1016/j.clim.2016.01.003 |
2016 |
Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent. |
BCL10 |
| 70 |
26776161 |
10.1038/onc.2015.493 |
2016 |
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. |
BCL10 |
| 71 |
26884334 |
10.1074/jbc.M116.717322 |
2016 |
Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain. |
BCL10 |
| 72 |
27006117 |
10.1242/jcs.185025 |
2016 |
The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. |
BCL10 |
| 73 |
27070692 |
10.1016/j.ccell.2016.03.018 |
2016 |
Killing Lymphoma with Smac-Mimetics: As Easy as ABC? |
BCL10 |
| 74 |
27070702 |
10.1016/j.ccell.2016.03.006 |
2016 |
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. |
BCL10 |
| 75 |
27071417 |
10.1042/BCJ20160270 |
2016 |
Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation. |
BCL10 |
| 76 |
27135977 |
10.1097/MOH.0000000000000257 |
2016 |
Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. |
BCL10 |
| 77 |
27452667 |
10.1016/j.semcancer.2016.07.003 |
2016 |
MALT lymphoma: A paradigm of NF-κB dysregulation. |
BCL10 |
| 78 |
27509941 |
NA |
2016 |
E1/E2 of Hepatitis C Virus Genotype4 and Apoptosis. |
BCL10 |
| 79 |
27566587 |
10.18632/oncotarget.11548 |
2016 |
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. |
BCL10 |
| 80 |
27777308 |
10.1074/jbc.M116.754028 |
2016 |
Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling. |
BCL10 |
| 81 |
24681956 |
10.1038/onc.2014.43 |
2015 |
B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway. |
BCL10 |
| 82 |
25391967 |
10.1007/s11060-014-1655-3 |
2015 |
Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system. |
BCL10 |
| 83 |
25556945 |
10.1016/j.chembiol.2014.10.021 |
2015 |
Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas. |
BCL10 |
| 84 |
25569716 |
10.1038/ncomms6908 |
2015 |
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma. |
BCL10 |
| 85 |
25956014 |
10.1016/j.jaci.2015.02.037 |
2015 |
Advances in basic and clinical immunology in 2014. |
BCL10 |
| 86 |
26202083 |
10.3892/ijmm.2015.2290 |
2015 |
Bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells. |
BCL10 |
| 87 |
26277595 |
10.1016/j.jaci.2015.06.031 |
2015 |
Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity. |
BCL10 |
| 88 |
26525107 |
10.1038/ncomms9777 |
2015 |
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. |
BCL10 |
| 89 |
26615705 |
10.1016/j.anndiagpath.2015.10.001 |
2015 |
Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma. |
BCL10 |
| 90 |
26668357 |
10.1073/pnas.1507459112 |
2015 |
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. |
BCL10 |
| 91 |
26711259 |
10.1128/MCB.00876-15 |
2015 |
Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181. |
BCL10 |
| 92 |
23846624 |
10.14670/HH-29.77 |
2014 |
BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study. |
BCL10 |
| 93 |
24375035 |
10.1002/jcp.24543 |
2014 |
The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders. |
BCL10 |
| 94 |
24411492 |
10.1016/j.cytogfr.2013.12.008 |
2014 |
The CBM signalosome: potential therapeutic target for aggressive lymphoma? |
BCL10 |
| 95 |
24491438 |
10.1158/2159-8290.CD-13-0915 |
2014 |
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. |
BCL10 |
| 96 |
24497531 |
10.1182/blood-2013-05-504019 |
2014 |
A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. |
BCL10 |
| 97 |
24641824 |
10.1016/j.bbagen.2014.03.011 |
2014 |
Degraded λ-carrageenan activates NF-κB and AP-1 pathways in macrophages and enhances LPS-induced TNF-α secretion through AP-1. |
BCL10 |
| 98 |
24732096 |
10.4161/cc.28707 |
2014 |
BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response. |
BCL10 |
| 99 |
24917592 |
10.1126/scisignal.2005169 |
2014 |
T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. |
BCL10 |
| 100 |
25087226 |
10.1016/j.jaci.2014.06.015 |
2014 |
The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency. |
BCL10 |
Datasets
Models
